Pearson will be responsible for the day-to-day operations at the fluid handling component manufacturing plant. He was previously business operations manager at Weetabix (Northamptonshire, UK) and site manager at Nampak Plastics Europe (Buckinghamshire, UK).
Diba, part of the multinational Halma technology group, provides custom engineered fluid handling components and design services. The company is headquartered in Danbury, Connecticut, US with global locations in the UK, China, and Japan.
Diba names new general manager
Mick Pearson takes responsibility for the Cambridge, UK fluid handling component plant
You may also like
Manufacturing
IMA Life-Sharp Sterile Manufacturing partnership strengthened with aseptic technology facility
Sharp's expanded facility in Massachusetts will include the installation of a fully automated IMA Life isolated filling line for Ready-To-Use (RTU) vials, addressing demand for US-based aseptic fill-finish services
Manufacturing
Cellistic launches three new iPSC-based GMP platforms to advance immuno-oncology and regenerative therapies
The three new iPSC-derived GMP manufacturing platforms, Echo-T, Echo-Cardio and Echo-Endothelial, expand the company’s Echo portfolio and are designed to improve scalability and manufacturability across immuno-oncology and regenerative medicine programmes
Manufacturing
The role of vacuum drying in battery manufacturing: From precursors to cell assembly
Lithium-ion battery manufacturers place enormous emphasis on material purity, structural integrity, and process control. Vacuum drying, used at both the precursor and electrode stages, has become an important step in achieving these performance and safety targets. Let’s explore where and how vacuum drying fits into modern battery production and how Powder Systems Ltd’s tray drying technology supports this growing need
Manufacturing
Jubilant Biosys doubles chemistry capacity with new Noida facility in India
The company has announced the opening of a new discovery and preclinical facility in Noida, combining discovery and early-phase scale-up capabilities with R&D labs and two pilot plants to meet growing demand for FFS contracts
Manufacturing
Aragen launches CHOMax platform to accelerate DNA-to-IND biologics development
The platform is designed to deliver IND-enabling clinical supply in around 10 months for suitable IgG antibodies, combining CHO cell line development, process and analytical development and GMP drug substance support to reduce timelines